top of page
NEWSROOM
Subscribe for News and Insights
Thanks for submitting!
Subscribe
CLIENT & PORTFOLIO NEWS
SETH YAKATAN NEWS & MEDIA
ARCHIVE
Search
GW Pharma's cannabis-based medicine to be tested in dementia
Alliqua BioMedical to spin off and merge its Contract Manufacturing Business with TO Pharmaceuticals
Katan Associates International
Sirnaomics cleared to start first trial of RNAi lead in cancer
Seth Yakatan Wins Life Sciences Strategic Consulting Firm Award
Recent Developments In Biotechnology
This Week's Biotech Developments
Kalytera's cannabis-based GVHD drug gathers steam
Biotech Developments to Watch
Sirnaomics Closed Series C1 Financing of $25 Million and Expands Clinical Programs of Anti-Fibrosis
BIO USA
GFPD Conference
FitLife Brands Announces First Quarter 2018 Results
Dr. Steven Long Joins Sirnaomics Senior Management Team as Head of China Clinical Studies
Investor Update
FitLife Brands Announces 2017 Results
NEUROTECH
Leading ovarian cancer expert Dr Andrew Stephens appointed to Invion’s advisory board
Invion secures research alliance with Hudson Institute of Medical Research
Kalytera Initiates Program
4
5
6
7
8
bottom of page
